Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 475 (RNA5SP475) is a processed pseudogene that is homologous to the functional 5S ribosomal RNA gene but contains sequence changes or truncations that make it nonfunctional[2][4]. Processed pseudogenes typically arise from the reverse transcription of an RNA molecule and its subsequent insertion back into the genome without the regulatory elements or coding capacity needed for biological activity[2][4]. 5S rRNA itself is a highly conserved structural and functional component of the large ribosomal subunit in eukaryotes, but the pseudogene variant does not contribute to ribosome structure or function[1][3]. Pseudogenes like RNA5SP475 may be detected through genomic sequencing and are typically classified as non-coding elements with no current evidence supporting therapeutic or diagnostic relevance[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 475 (RNA5SP475).